Table 2. Summary of some research articles describing different SNEDDS formulations .

Drug	Excipients	Formulation	Bioavailability (in-vitro/in-vivo results)	Reference
Cyclosporine A	Labrafil® Transcutol®, Cremophor®	Controlled release osmotic pump tablets	80% drug release in 12 h	85
Ziprasidone	Capmul® Labrasol®, PEG 400*	Sustained release pellets	95% drug release within 12 h	86
Embelin	Capryol®, Acrosyl®,PEG 400*	Tablets	96.5% drug released within 15 min in-vitro compared to 5% pure drug	87
Glimepiride	Miglyol®, Tween®, PEG 400*	S-SNEDDS powder-filled hard gelatin capsules	95% in-vitro drug release within 1 h	88
Valsartan	Capmul®, Labrasol®, Tween®	Tablets	3–3.5-Fold increased dissolution rate with almost all drug released within 1 h	89

*Polyethylene glycol (PEG 400)